Cargando…
Expression of p11 in Patients with Depression
(1) Background: Some studies suggest that the p11 protein, belonging to the so-called S100 family and located, i.a., in the nucleus accumbens of the brain, is responsible for the occurrence of depression. This protein is encoded by the S100A10 gene. The aim of our study was to evaluate the expressio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570916/ https://www.ncbi.nlm.nih.gov/pubmed/36233614 http://dx.doi.org/10.3390/jcm11195743 |
_version_ | 1784810230426632192 |
---|---|
author | Gałecka, Małgorzata Bliźniewska-Kowalska, Katarzyna Gałecki, Piotr Szemraj, Janusz Orzechowska, Agata |
author_facet | Gałecka, Małgorzata Bliźniewska-Kowalska, Katarzyna Gałecki, Piotr Szemraj, Janusz Orzechowska, Agata |
author_sort | Gałecka, Małgorzata |
collection | PubMed |
description | (1) Background: Some studies suggest that the p11 protein, belonging to the so-called S100 family and located, i.a., in the nucleus accumbens of the brain, is responsible for the occurrence of depression. This protein is encoded by the S100A10 gene. The aim of our study was to evaluate the expression of the S100A10 gene at the mRNA and protein levels in patients with depressive disorders and to determine the impact of p11 in the etiopathogenesis of depression; (2) Methods: A total of 290 people (190 depressed patients, 100 healthy controls) participated in the study. Socio-demographic and clinical data were collected. The severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale (HDRS). Venous blood was collected from all participants. RT-PCR was used to evaluate gene expression at the mRNA level, while enzyme-linked immunosorbent assay (ELISA) was used to evaluate gene expression at the protein level; (3) Results: The results indicate slightly increased S100A10 gene expression (both at the protein and mRNA levels) in patients with depression, but these values do not reach statistical significance; (4) Conclusions: Due to the fact that the study was limited by the participation of patients already undergoing antidepressant treatment, its results may confirm that pharmacological treatment affecting serotonin neurotransmission is effective in upregulation of p11 in patients with depression. |
format | Online Article Text |
id | pubmed-9570916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95709162022-10-17 Expression of p11 in Patients with Depression Gałecka, Małgorzata Bliźniewska-Kowalska, Katarzyna Gałecki, Piotr Szemraj, Janusz Orzechowska, Agata J Clin Med Article (1) Background: Some studies suggest that the p11 protein, belonging to the so-called S100 family and located, i.a., in the nucleus accumbens of the brain, is responsible for the occurrence of depression. This protein is encoded by the S100A10 gene. The aim of our study was to evaluate the expression of the S100A10 gene at the mRNA and protein levels in patients with depressive disorders and to determine the impact of p11 in the etiopathogenesis of depression; (2) Methods: A total of 290 people (190 depressed patients, 100 healthy controls) participated in the study. Socio-demographic and clinical data were collected. The severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale (HDRS). Venous blood was collected from all participants. RT-PCR was used to evaluate gene expression at the mRNA level, while enzyme-linked immunosorbent assay (ELISA) was used to evaluate gene expression at the protein level; (3) Results: The results indicate slightly increased S100A10 gene expression (both at the protein and mRNA levels) in patients with depression, but these values do not reach statistical significance; (4) Conclusions: Due to the fact that the study was limited by the participation of patients already undergoing antidepressant treatment, its results may confirm that pharmacological treatment affecting serotonin neurotransmission is effective in upregulation of p11 in patients with depression. MDPI 2022-09-28 /pmc/articles/PMC9570916/ /pubmed/36233614 http://dx.doi.org/10.3390/jcm11195743 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gałecka, Małgorzata Bliźniewska-Kowalska, Katarzyna Gałecki, Piotr Szemraj, Janusz Orzechowska, Agata Expression of p11 in Patients with Depression |
title | Expression of p11 in Patients with Depression |
title_full | Expression of p11 in Patients with Depression |
title_fullStr | Expression of p11 in Patients with Depression |
title_full_unstemmed | Expression of p11 in Patients with Depression |
title_short | Expression of p11 in Patients with Depression |
title_sort | expression of p11 in patients with depression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570916/ https://www.ncbi.nlm.nih.gov/pubmed/36233614 http://dx.doi.org/10.3390/jcm11195743 |
work_keys_str_mv | AT gałeckamałgorzata expressionofp11inpatientswithdepression AT blizniewskakowalskakatarzyna expressionofp11inpatientswithdepression AT gałeckipiotr expressionofp11inpatientswithdepression AT szemrajjanusz expressionofp11inpatientswithdepression AT orzechowskaagata expressionofp11inpatientswithdepression |